We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Dips More Than Broader Market: What You Should Know
Read MoreHide Full Article
In the latest trading session, Albemarle (ALB - Free Report) closed at $93.27, marking a -3.81% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.31% for the day. Meanwhile, the Dow experienced a drop of 0.25%, and the technology-dominated Nasdaq saw a decrease of 1.38%.
Heading into today, shares of the specialty chemicals company had lost 8.34% over the past month, lagging the Basic Materials sector's loss of 3.42% and the S&P 500's gain of 0.87%.
The investment community will be closely monitoring the performance of Albemarle in its forthcoming earnings report. The company is scheduled to release its earnings on November 4, 2026. The company's earnings per share (EPS) are projected to be $2.56, reflecting a 1447.37% increase from the same quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $1.49 billion, up 14.09% from the year-ago period.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $11.15 per share and revenue of $6.1 billion, indicating changes of +1511.39% and +18.54%, respectively, compared to the previous year.
Investors might also notice recent changes to analyst estimates for Albemarle. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 2.14% decrease. As of now, Albemarle holds a Zacks Rank of #3 (Hold).
In terms of valuation, Albemarle is currently trading at a Forward P/E ratio of 8.7. For comparison, its industry has an average Forward P/E of 15.85, which means Albemarle is trading at a discount to the group.
It is also worth noting that ALB currently has a PEG ratio of 0.58. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As of the close of trade yesterday, the Chemical - Diversified industry held an average PEG ratio of 1.22.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 207, which puts it in the bottom 16% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
View the Zacks #1 Rank List
Image: Bigstock
Albemarle (ALB) Dips More Than Broader Market: What You Should Know
In the latest trading session, Albemarle (ALB - Free Report) closed at $93.27, marking a -3.81% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.31% for the day. Meanwhile, the Dow experienced a drop of 0.25%, and the technology-dominated Nasdaq saw a decrease of 1.38%.
Heading into today, shares of the specialty chemicals company had lost 8.34% over the past month, lagging the Basic Materials sector's loss of 3.42% and the S&P 500's gain of 0.87%.
The investment community will be closely monitoring the performance of Albemarle in its forthcoming earnings report. The company is scheduled to release its earnings on November 4, 2026. The company's earnings per share (EPS) are projected to be $2.56, reflecting a 1447.37% increase from the same quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $1.49 billion, up 14.09% from the year-ago period.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $11.15 per share and revenue of $6.1 billion, indicating changes of +1511.39% and +18.54%, respectively, compared to the previous year.
Investors might also notice recent changes to analyst estimates for Albemarle. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 2.14% decrease. As of now, Albemarle holds a Zacks Rank of #3 (Hold).
In terms of valuation, Albemarle is currently trading at a Forward P/E ratio of 8.7. For comparison, its industry has an average Forward P/E of 15.85, which means Albemarle is trading at a discount to the group.
It is also worth noting that ALB currently has a PEG ratio of 0.58. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As of the close of trade yesterday, the Chemical - Diversified industry held an average PEG ratio of 1.22.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 207, which puts it in the bottom 16% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.